CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- 8-K Event Results of operations
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change · Other events
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results · Other events
- 8-K Event Other events
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · New debt or obligation · Executive or director change · Other events
- 4 Insider Changes in Ownership
- 25-NSE Other Notification of Removal from Listing
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · Unregistered share sale · Other events
- 8-K Event Delisting notice
- 3 Insider Initial Statement of Ownership
Page 32 of 42 · 833 filings